SciELO - Scientific Electronic Library Online

 
vol.8 issue2 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Medicina clínica y social

On-line version ISSN 2521-2281

Med. clín. soc. vol.8 no.2 Santa Rosa del Aguaray Aug. 2024

https://doi.org/10.52379/mcs.v8i2.369 

Artículo original

Mortality from Infections Associated with Health Care in Patients with HIV in Paraguay

Mortalidad por Infecciones Asociadas a la atención en la Salud en Pacientes con VIH en Paraguay

Gladys López1 

Gloria Aguilar2  3 
http://orcid.org/0000-0001-8341-701X

Carlos Miguel Ríos-González2  3 
http://orcid.org/0009-0000-9929-0551

1Ministerio de Salud Pública y Bienestar Social, Asunción, Paraguay

2Universidad Sudamericana, Facultad de Ciencias de la Salud, Pedro Juan Caballero, Paraguay

3Ministerio de Salud Pública y Bienestar Social, Instituto Nacional de Salud, Asunción, Paraguay.


ABSTRACT

Introduction:

Few studies have evaluated HAIs in an HIV population; however, studies have suggested that patients with HIV are at a higher risk of contracting HAI because they have high rates of hospitalization and longer hospital stays.

Objective:

To determine mortality due to Infections Associated with Health Care in Patients with HIV in Paraguay from January to December 2018 to 2021.

Methodology:

This was an observational, descriptive, and cross-sectional study. The study population consisted of people over 18 years of age who died with a diagnosis of HIV infection and IAAS of both sexes during that period. The study variables were demographic, HIV-related, Baseline Viral Load, Stage of HIV infection at the time of diagnosis, Time from HIV diagnosis to death (in months), comorbidities at the time of death, microorganism isolation, presence, and location. of IAAS.

Results:

93 patients with IAAS were included in the study, of which 34.4% (32) were between 20 and 29 years of age and 19.3% (18). Regarding the type of population, 79.3% (73) were in the general population, 77.6% (59) were diagnosed with AIDS, and 68.6% (59) had a baseline CD4 count of less than 200 cells/mm3. The mortality rate in 2020 was 6.7%, during 2018 it was 6.5% and in 2021 it and 6.4%.

Conclusion:

People with HIV, especially those who have been diagnosed in advanced stages of the disease, are more likely to develop HAIs and are related to mortality. This is due to the presence of multiple opportunistic infections and comorbidities that favor a high number of hospitalizations and longer hospital stays.

Keywords: HIV; Infections associated with Health Care; Paraguay.

RESUMEN

Introducción:

Hay pocos estudios que hayan evaluado IAAS en una población con VIH, sin embargo, los estudios sugirieron que los pacientes con VIH tienen un mayor riesgo de contraer una IAAS porque tienen altas tasas de hospitalización y estancias hospitalarias más largas.

Objetivo:

determinar la mortalidad por Infecciones Asociadas a la atención en la Salud en Pacientes con VIH en Paraguay durante los meses de enero a diciembre del año 2018 a 2021.

Metodología:

Estudio observacional, descriptivo de corte transversal. La población de estudio la constituyeron las personas fallecidas con diagnóstico de infección por VIH e IAAS de ambos sexos, mayor de 18 años de edad, durante ese período. Las variables del estudio fueron demográficas, relacionadas al VIH, Carga Viral basal, Estadio de infección por VIH al momento del diagnóstico, Tiempo desde el diagnóstico de VIH hasta el óbito (meses), comorbilidades al momento del óbito, microorganismo aislado, presencia y localización de IAAS.

Resultados:

Fueron incluidos en el estudio 93 pacientes con IAAS, de los cuales el 34,4% (32) tuvo una edad entre 20 a 29 años, el 19,3% (18). En cuanto al tipo de población el 79.3% (73) fue población general, 77.6% (59) fue diagnosticado como sida, 68.6% (59) tenían un recuento basal de CD4 menor a 200 células/mm3. La tasa de mortalidad durante el 2020 fue 6,7%, durante el 2018 fue 6,5% y durante el 2021 fue de 6,4%.

Conclusión:

las personas con VIH en especial aquellas que han sido diagnosticadas en estadios avanzados de la enfermedad tienen mayor posibilidad de desarrollar IAAS y estar relacionadas a la mortalidad. Esto se debe a la presencia de múltiples infecciones oportunistas y comorbilidades que favorece el alto número de internaciones y las estancias mas prolongadas.

Palabras clave: VIH; Infecciones asociadas a la Atención en Salud; Paraguay.

Introduction

HIV is not only a public health problem, since once widespread, the epidemic has far-reaching consequences for all social sectors and for the development itself. It can decimate the workforce, create large numbers of orphans, exacerbate poverty and inequality, and place tremendous pressure on health and social services1. According to data from the Ministry of Public Health and Welfare (MSPyBS), since the beginning of the epidemic in 1985, until 2021, a total of 25 050 people were registered with an HIV diagnosis, of which 6 967 were categorized as AIDS and the accumulated mortality until 2022 was 9,413 cases2.

Healthcare-associated infections (HAIs) are complications that increase patient morbidity and mortality, length of hospital stay, and related costs, and have a significant impact on the healthcare system3. Few studies have evaluated HAIs in an HIV population4,5; however, studies have suggested that patients with HIV are at an increased risk of contracting an HAI because they have high rates of hospitalization and longer hospital stays, and they are at high risk of contracting infections considering their immunosuppressed status4-6.

These infections are characterized by being acquired during medical care and can be caused by bacteria, viruses, fungi, or parasites7. The risk of developing HAI is higher in patients with HIV infection than in those without. This is because HIV weakens the immune system, making it more susceptible to infections8.

The use of invasive devices, presence of opportunistic diseases, renal failure, and ICU stay are risk factors for contracting HAIs in an HIV-positive population9. Furthermore, there is no consensus on the most common HAIs in patients with HIV, and whether this population has a higher risk of acquiring HAIs caused by multidrug-resistant organisms (MDRO)10. The objective of this study was to determine mortality due to infections associated with healthcare in patients with HIV in Paraguay from January to December 2018 to 2021.

Methodology

An observational, descriptive, cross-sectional study was carried out with non-probabilistic convenience sampling on mortality due to Infections Associated with Health Care in Patients with HIV in Paraguay from January to December 2018 to 2021.

The study population consisted of people over 18 years of age who died with a diagnosis of HIV infection and IAAS of both sexes during that period. The study variables were demographic (age, sex, place of residence, population), HIV-related (Baseline CD4 count (cells/mm3), Baseline Viral Load (RNA copies/mL plasma), Stage of HIV infection at the time of diagnosis, Time from HIV diagnosis to death (months), comorbidities at the time of death, isolated microorganisms, and presence and location of IAAS.

HAIs were defined as urinary tract infections (UTI), bloodstream infections (STI), respiratory tract infections (RTI), or a combination of these infections, which developed at least 48 hours after hospital admission. If a patient was discharged and then readmitted within 72 h, this was also considered an HAI. The study was approved by the Institutional Ethics Committee, and the ethical principles of the Helsinki for biomedical research were adhered to. The data were entered into a Microsoft Office Excel© 2016 spreadsheet, after data quality control, the variables were exported and analyzed with the Stata 17.0® statistical software. The results were presented as measures of central tendency, dispersion, and a table of proportions.

Results

93 patients with IAAS were included in the study, of which 34.4% were between 20 and 29 years old, 19.3% were between 40 and 49 years old, 73.1% were male, and 74.2% resided in Asunción and Central. Regarding the type of population, 79.3% were in the general population, 77.6% were diagnosed with AIDS, and 68.6% had a baseline CD4 count of less than 200 cells/mm3. Of the 40.7%, the time from HIV diagnosis to death was greater than 40 months, and the most frequent comorbidity was AIDS-related cancer (Table 1). Of the microorganisms isolated from patients with healthcare-associated infections, eight were Klebsiella pneumoniae, five were Pseudomonas spp., and four were Escherichia coli and Acinetobacter baumannii. Regarding the location of the IAAS, 59.1% were due to NIH, 8.6% due to UTI, and 6.5% due to bacteremia (Table 2). The mortality rate during 2020 was 6.7%, during 2018 it was 6.5% and during 2021 it was 6.4% (Table 3).

Table 1 Demographic, clinical, and laboratory characteristics of people with hiv who died from healthcare-associated infections between 2018 and 2022 (n=93 

Table 2 Microorganisms isolated and location of infections (n=93). 

Table 3 Frequency of mortality associated with hais per year (n=93 

Discussion

Mortality due to HIV/AIDS is mainly associated with late diagnosis, poor adherence to treatment, and no treatment11. These factors favor an increase in opportunistic infections and neoplasia, which are responsible for most deaths in untreated patients3,12. Furthermore, virological failure is associated with high mortality, which highlights the need to pay greater attention to this at-risk population, and in untreated cases, death usually occurs two years after the onset of clinical symptoms3,9.

The fact that most patients in this study were diagnosed with AIDS indicates that the infection was detected at an advanced stage. Hu X et al.12) and Khan MA13) highlighted that this may be due to factors such as lack of access to medical care, stigmatization, and discrimination faced by people with HIV/AIDS.

A low baseline CD4 count is an indicator of advanced infection14. CD4 is a type of white blood cell that helps the immune system fight infections. When the CD4 count is low, the immune system is weakened and more susceptible to opportunistic infections, which predisposes to HAIs, as highlighted by Castro-Lima VAC et al.6) and Rojas D7.

Although the study found a long time from HIV diagnosis to death, it indicates that the disease progressed slowly, which differs from the findings of Gao et al.15, GBD 2015 Mortality and Causes of Death Collaborators16, and Deng et al.17. Late diagnosis continues to represent a problem in Paraguay, with a significant diagnostic gap owing to the country's diagnostic gap2. The most frequent comorbidity was AIDS, which indicates that opportunistic infections were the most common cause of death in these patients2,3. The high prevalence of IAAS in patients with HIV is explained by immunosuppression caused by the virus. HIV attacks cells of the immune system, hindering their ability to fight infections. Consequently, HIV patients are more susceptible to bacterial, fungal, and viral infections18-20.

In general, the results of this study showed that HIV/AIDS infection in Paraguay continues to be a public health problem that disproportionately affects men. Diagnosis remains late in the advanced stages of the disease in both sexes, with a high mortality rate. Measures need to be implemented to improve access to diagnosis, medical care, and infection prevention to reduce the impact of the disease on public health. The combined prevention strategy for HIV infection, defined by the UNAIDS, aims to reduce new HIV infections. Furthermore, it was found that during this study, 1492 people died, of which 6.2% were attributed to IAAS and remained constant during the four years of the analyzed cohort.

The limitations of the study mainly focus on the quality of the information available on HIV-related deaths; therefore, it is extremely relevant to propose strategies to improve the quality of the information. In conclusion, it is possible to indicate that people with HIV, especially those who have been diagnosed in advanced stages of the disease, are more likely to develop HAIs and are related to mortality. This is due to the presence of multiple opportunistic infections and comorbidities that favor a high number of hospitalizations and longer hospital stays.

REFERENCES

1. Ríos-González CM. Reflexiones sobre el VIH y la salud fronteriza. Rev. virtual Soc. Parag. Med. Int. 2023;10(2): 151-153. 10.18004/rvspmi/2312-3893/2023.10.02.151 [ Links ]

2. Ministerio de Salud Publica y Bienestar Social. Situación Epidemiologica del VIH en Paraguay. Disponible en: https://www.mspbs.gov.py/dependencias/pronasida/adjunto/252034-INFORMEEPIDEMIOLOGICOVIH2022.pdf Links ]

3. Haque M, Sartelli M, McKimm J, Abu Bakar M. Health care-associated infections - an overview. Infect Drug Resist. 2018;11:2321-2333. 10.2147/idr.s177247. [ Links ]

4. Mitha M, Furuya EY, Larson E. Risk of healthcare associated infections in HIV positive patients. J Infect Prev. 2014;15(6):214-220. 10.1177/1757177414548694. [ Links ]

5. Reis DTS, Carneiro ICRS, Neves DCO, Marsola LR, Sousa RCM. Healthcare-associated infections among HIV-positive and HIV/AIDS-negative patients: a casuistic from the Amazonian Region. Rev Pan-Amaz Saude. 2013;4(2):27-32. 10.5123/S2176-62232013000200004. [ Links ]

6. Castro-Lima VAC, Borges IC, Joelsons D, Sales VVT, Guimaraes T, Ho YL, Costa SF, Moura MLN. Impact of human immunodeficiency virus infection on mortality of patients who acquired healthcare associated infection in critical care unit. Medicine (Baltimore). 2019;98(23):e15801. 10.1097/md.0000000000015801. [ Links ]

7. Rojas D, Wendell D, Ferguson PhD TF, Robinson WT, Trepka MJ, Straif-Bourgeois SC. HIV-associated comorbidities as mediators of the association between people living with HIV and hospital-acquired infections. Am J Infect Control. 2019;47(12):1500-1504. 10.1016/j.ajic.2019.05.028. [ Links ]

8. Zalmanovich A, Ben-Ami R, Rahav G, Alon D, Moses A, Olshtain-Pops K, Weinberger M, Shitrit P, Katzir M, Gottesman BS, Chowers M. Healthcare-associated Pneumocystis jirovecii Pneumonia (PJP) Infection in HIV-negative Adults: a Multicenter Study. Isr Med Assoc J. 2021;23(5):312-317. https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2021&month=05&page=312Links ]

9. Nasiri N, Sharifi A, Ghasemzadeh I, Khalili M, Karamoozian A, Khalooei A, Beigzadeh A, Haghdoost A, Sharifi H. Incidence, accuracy, and barriers of diagnosing healthcare-associated infections: a case study in southeast Iran. BMC Infect Dis. 2023;23(1):171. 10.1186/s12879-023-08122-1. [ Links ]

10. Ganczak M, Barss P. Nosocomial HIV infection: epidemiology and prevention--a global perspective. AIDS Rev. 2008;10(1):47-61. https://pubmed.ncbi.nlm.nih.gov/18385780/ Links ]

11. Ertunc B, Kaya S, Koksal I. Clinico-Epidemiological Analysis of HIV/AIDS Patients. Eurasian J Med. 2016;48(3):157-161. 10.5152/eurasianjmed.2016.15203. [ Links ]

12. Hu X, Liang B, Zhou C, Jiang J, Huang J, Ning C, Liu J, Zhou B, Zang N, Lai J, Chen R, Liao Y, Pan P, Liu X, Lan G, Pang X, Ye L, Shen Z, Liang H. HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study. AIDS Res Ther. 2019;16(1):6. 10.1186/s12981-019-0221-7. [ Links ]

13. Khan MA, Sehgal A. Clinico-epidemiological and Socio-behavioral Study of People Living with HIV/AIDS. Indian J Psychol Med. 2010;32(1):22-8. 10.4103/0253-7176.70523. [ Links ]

14. Balasundaram A, Sarkar S, Hamide A, Lakshminarayanan S. Socioepidemiologic profile and treatment-seeking behaviour of HIV/AIDS patients in a tertiary-care hospital in south India. J Health Popul Nutr. 2014;32(4):587-94. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438688/Links ]

15. Gao D, Zou Z, Dong B, Zhang W, Chen T, Cui W, Ma Y. Secular trends in HIV/AIDS mortality in China from 1990 to 2016: Gender disparities. PLoS One. 2019;14(7):e0219689. 10.1371/journal.pone.0219689. [ Links ]

16. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459-1544. 10.1016/s0140-6736(16)31012-1 [ Links ]

17. Deng P, Chen M, Si L. Temporal trends in inequalities of the burden of HIV/AIDS across 186 countries and territories. BMC Public Health. 2023;23(1):981. 10.1186/s12889-023-15873-8. [ Links ]

18. Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev. 2011;24(1):141-73. 10.1128/cmr.00027-10. [ Links ]

19. Owusu AY. Experiences of new diagnoses among HIV-positive persons: implications for public health. BMC Public Health. 2022;22(1):538. 10.1186/s12889-022-12809-6. [ Links ]

20. Tchakoute CT, Liu J, Cohen B, Larson E. Risk Factors and Temporal Trends of Hospital-Acquired Infections (HAIs) Among HIV Positive Patients in Urban New York City Hospitals: 2006 to 2014. Rev Recent Clin Trials. 2017;12(1):44-50. 10.2174/1574887111666160906094140. [ Links ]

AUTHORS CONTRIBUTIONS

0GL: conceived and designed the study. In addition, he led the data collection and writing of the methodology and results sections of the article. Supervised the development of the project and provided critical input to the final version of the manuscript. GA: collaborated in the design of the study and was primarily responsible for the statistical analysis of the data. She contributed significantly to the interpretation of the results and wrote the corresponding sections of the manuscript. CMRG: participated in data collection and analysis and contributed to writing the discussion of the study. Provided key perspectives for the interpretation of the results from a clinical and epidemiological context. All authors have given their final approval of the manuscript to be published.

Funding: The authors received no financial support for the research, authorship, and/or publication of this article

Responsible editor Gladys Estigarribia, PhD, 0000-0001-8058-9369, Universidad Nacional de Caaguazú, Coronel Oviedo, Paraguay.

Received: November 10, 2023; Revised: February 11, 2023; Accepted: May 08, 2024

Corresponding author: Carlos Miguel Ríos-González. Ministerio de Salud Pública y Bienestar Social, Paraguay. Email: carlosmigue_rios@live.com

Conflicts of interests:

The authors declare that there is no conflict of interest.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License